Headlines

Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Drug development has long relied on animal models, but differences between species mean what works in animals doesn’t always translate to humans, and most drugs still fail during development. Intero Biosystems, a Denver-based startup, is developing human intestinal organoids, lab-grown tissue that mimics the gut, as another way to study how drugs and other compounds…

Read More

Starknet Considers Becoming an L1 to Reach Quantum Resistance by 2027

Starknet’s bridge still relies on elliptic-curve cryptography, creating a potential failure point if Ethereum upgrades more slowly. Starknet is considering becoming a standalone Layer 1 blockchain, with its builders targeting quantum-resistant security by 2027 as concerns grow about whether artificial intelligence could accelerate attacks on existing cryptography. The move would give the network more…

Read More

Shayne Coplan Renews Speculation About Polymarket Token

Coplan previously fueled token rumors by replacing XRP with “$POLY” in a list of leading cryptocurrencies posted on X last October. Polymarket CEO Shayne Coplan has renewed speculation about a native cryptocurrency after discussing an on-chain asset at the just-concluded TOKEN2049 conference in Singapore. However, he offered no launch date or airdrop details, leaving…

Read More